Skip to main content

People in the News: May 27, 2011 (rev. 1)

Premium

Exosome Diagnostics, a developer of biofluid-based molecular diagnostic tests for personalized medicine, has selected John Quackenbush to serve on its scientific advisory board.

Quackenbush is professor of computational biology and bioinformatics at the Dana-Faber Cancer Institute. Currently, his research focuses include the identification of expression fingerprints and genomic alterations that are relevant to colon and breast tumor metastasis; the development of novel computational approaches for the interpretation of large-scale datasets; and methods for data integration to facilitate gene discovery.

He completed a PhD in theoretical physics followed by a two-year postdoctoral position in experimental particle physics and phenomenology both at the University of California, Los Angeles.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.